+Search query
-Structure paper
Title | Contributions of Hyperactive Mutations in M pro from SARS-CoV-2 to Drug Resistance. |
---|---|
Journal, issue, pages | Acs Infect Dis., Vol. 10, Page 1174-1184, Year 2024 |
Publish date | Jul 25, 2022 (structure data deposition date) |
Authors | Flynn, J.M. / Zvornicanin, S.N. / Tsepal, T. / Shaqra, A.M. / Kurt Yilmaz, N. / Jia, W. / Moquin, S. / Dovala, D. / Schiffer, C.A. / Bolon, D.N.A. |
External links | Acs Infect Dis. / PubMed:38472113 |
Methods | X-ray diffraction |
Resolution | 2 - 2.75 Å |
Structure data | PDB-8dt9: PDB-8e4w: PDB-8e5c: |
Chemicals | ChemComp-DMS: ChemComp-V2M: ChemComp-NA: ChemComp-HOH: ChemComp-4WI: ChemComp-CL: |
Source |
|
Keywords | VIRAL PROTEIN / Coronavirus / COVID-19 / COVID / PROTEASE / DRUG RESISTANCE / COMPLEX / HYDROLASE / DURG DISCOVERY / MAIN PROTEASE / MPRO / SUBSTRATE COMPLEX / Pfizer IV compound / PF-00835231 / L141R / HYDROLASE/INHIBITOR / N142P / HYDROLASE-INHIBITOR complex / L50F / Nirmatrelvir / VIRAL PROTEIN-HYDROLASE-INHIBITOR complex |